Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 06-May-20 7:30 PM View:  | Lyra Therapeutics, Inc. (LYRA) | 05-May-20 | Conversion | 1,030,090 | -- | -- | 100% 0 to 1.03M | |
| 06-May-20 7:30 PM View: | Lyra Therapeutics, Inc. (LYRA) | 05-May-20 | Purchase | 62,500 | $16.00 | $1,000,000.00 | 6% 1.03M to 1.09M | |
| 06-May-20 7:30 PM View: | Lyra Therapeutics, Inc. (LYRA) | 05-May-20 | Sale | 9,674 | $16.00 | $154,784.00 | (< 1%) 1.11M to 1.1M | |
| 06-May-20 7:30 PM View: | Lyra Therapeutics, Inc. (LYRA) | 05-May-20 | Exercise (in-the money or at-the-money) | 17,932 | $8.63 | $154,753.00 | 2% 1.09M to 1.11M | |
| 18-Dec-19 4:50 PM View: | Phreesia, Inc. (PHR) | 17-Dec-19 | Sale | 357,121 | $24.48 | $8,741,960.00 | (10%) 3.57M to 3.21M | |
| 24-Jul-19 4:16 PM View: | Phreesia, Inc. (PHR) | 22-Jul-19 | Conversion | 3,968,010 | -- | -- | 100% 0 to 3.97M | |
| 24-Jul-19 4:16 PM View: | Phreesia, Inc. (PHR) | 22-Jul-19 | Sale | 396,799 | $18.00 | $7,142,380.00 | (10%) 3.97M to 3.57M | |
| 17-Jul-19 6:09 PM View: | Cardlytics, Inc. (CDLX) | 17-Jul-19 | Market Sale (Planned) Duplicate | 27,781 | $27.45 | $762,505.00 | (1%) 2.24M to 2.21M | (427%) |
| 17-Jul-19 6:09 PM View: | Cardlytics, Inc. (CDLX) | 16-Jul-19 | Market Sale (Planned) Duplicate | 20,962 | $27.87 | $584,188.00 | (< 1%) 2.26M to 2.24M | (419%) |
| 17-Jul-19 6:09 PM View: | Cardlytics, Inc. (CDLX) | 15-Jul-19 | Market Sale (Planned) Duplicate | 19,984 | $27.73 | $554,074.00 | (< 1%) 2.28M to 2.26M | (422%) |
| 11-Jun-19 6:27 PM View: | Cardlytics, Inc. (CDLX) | 07-Jun-19 | Market Sale Duplicate | 100,000 | $25.62 | $2,562,120.00 | (4%) 2.38M to 2.28M | (465%) |
| 06-Jun-19 8:09 PM View: | Cardlytics, Inc. (CDLX) | 06-Jun-19 | Market Sale Duplicate | 305 | $25.00 | $7,625.00 | (< 1%) 2.38M to 2.38M | (479%) |
| 06-Jun-19 8:09 PM View: | Cardlytics, Inc. (CDLX) | 05-Jun-19 | Market Sale Duplicate | 38,601 | $24.86 | $959,507.00 | (2%) 2.42M to 2.38M | (482%) |
| 06-Jun-19 8:09 PM View: | Cardlytics, Inc. (CDLX) | 04-Jun-19 | Market Sale Duplicate | 36,378 | $23.28 | $846,942.00 | (1%) 2.45M to 2.42M | (522%) |
| 30-May-19 8:20 PM View: | Cardlytics, Inc. (CDLX) | 28-May-19 | Market Sale Duplicate | 100,000 | $23.04 | $2,303,810.00 | (4%) 2.55M to 2.45M | (528%) |
| 14-Sep-18 4:38 PM View: | Cardlytics, Inc. (CDLX) | 13-Sep-18 | Sale | 50,000 | $25.56 | $1,278,180.00 | (2%) 2.6M to 2.55M | |
| 14-Sep-18 4:38 PM View: | Cardlytics, Inc. (CDLX) | 12-Sep-18 | Sale | 100,000 | $24.78 | $2,478,100.00 | (4%) 2.7M to 2.6M | |
| 09-Aug-18 9:33 PM View: | Cardlytics, Inc. (CDLX) | 09-Aug-18 | Option Exercise | 66,364 | $0.00 | $26.55 | 3% 2.64M to 2.7M | |
| 15-Feb-18 4:29 PM View: | Cardlytics, Inc. (CDLX) | 13-Feb-18 | Conversion | 2,636,260 | -- | -- | 100% 0 to 2.64M | |
| 20-Nov-17 5:28 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 20-Nov-17 | Conversion | 1,368,960 | -- | -- | 100% 0 to 1.37M | |
| 20-Nov-17 5:28 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 20-Nov-17 | Purchase Duplicate | 500,000 | $10.00 | $5,000,000.00 | 37% 1.37M to 1.87M | |
| 29-Jun-16 4:44 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 27-Jun-16 | Conversion | 1,712,700 | -- | -- | 4204% 40.74K to 1.75M | |
| 29-Jun-16 4:44 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 27-Jun-16 | Purchase | 150,000 | $14.00 | $2,100,000.00 | 9% 1.75M to 1.9M | |
| 19-Jun-15 6:23 PM View: | Genocea Biosciences, Inc. (GNCA) | 19-Jun-15 | Market Sale | 1,000 | $13.00 | $13,000.00 | (< 1%) 1.97M to 1.97M | 98% |
| 19-Jun-15 6:23 PM View: | Genocea Biosciences, Inc. (GNCA) | 18-Jun-15 | Market Sale | 29,004 | $13.04 | $378,212.00 | (1%) 2.0M to 1.97M | 98% |
| 17-Jun-15 7:09 PM View: | Genocea Biosciences, Inc. (GNCA) | 17-Jun-15 | Market Sale | 10,618 | $13.01 | $138,140.00 | (< 1%) 2.01M to 2.0M | 98% |
| 17-Jun-15 7:09 PM View: | Genocea Biosciences, Inc. (GNCA) | 16-Jun-15 | Market Sale | 46,000 | $13.24 | $609,040.00 | (2%) 2.06M to 2.01M | 98% |
| 14-May-15 9:27 PM View: | Atyr Pharma Inc (ATYR) | 12-May-15 | Conversion Duplicate | 1,827,990 | -- | -- | 100% 0 to 1.83M | |
| 04-Feb-15 4:30 PM View: | Ocular Therapeutix, Inc (OCUL) | 02-Feb-15 | Market Sale | 500,000 | $29.50 | $14,750,000.00 | (20%) 2.53M to 2.03M | 28% |
| 18-Aug-14 4:30 PM View: | Trevena, Inc. (TRVN) | 14-Aug-14 | Market Sale | 36,702 | $6.04 | $221,680.00 | (< 1%) 3.81M to 3.77M | 89% |
| 15-Aug-14 11:22 AM View: | Genocea Biosciences, Inc. (GNCA) | 14-Aug-14 | Market Sale | 6,755 | $13.01 | $87,882.60 | (< 1%) 2.06M to 2.06M | 98% |
| 15-Aug-14 4:30 PM View: | Trevena, Inc. (TRVN) | 13-Aug-14 | Market Sale | 5,700 | $6.12 | $34,884.00 | (< 1%) 3.81M to 3.81M | 89% |
| 15-Aug-14 11:22 AM View: | Genocea Biosciences, Inc. (GNCA) | 13-Aug-14 | Market Sale | 2,905 | $13.00 | $37,765.00 | (< 1%) 2.06M to 2.06M | 98% |
| 12-Aug-14 7:25 PM View: | Genocea Biosciences, Inc. (GNCA) | 12-Aug-14 | Market Sale | 20,990 | $13.03 | $273,500.00 | (1%) 2.09M to 2.06M | 98% |
| 12-Aug-14 7:25 PM View: | Genocea Biosciences, Inc. (GNCA) | 11-Aug-14 | Market Sale | 1,428 | $13.24 | $18,906.70 | (< 1%) 2.09M to 2.09M | 98% |
| 12-Aug-14 7:25 PM View: | Genocea Biosciences, Inc. (GNCA) | 08-Aug-14 | Market Sale | 41,376 | $13.41 | $554,852.00 | (2%) 2.13M to 2.09M | 98% |
| 31-Jul-14 6:32 PM View: | Ocular Therapeutix, Inc (OCUL) | 30-Jul-14 | Conversion | 2,530,010 | -- | -- | 100% 0 to 2.53M | |
| 15-Apr-14 8:46 PM View: | Cerulean Pharma Inc. (DARE) | 15-Apr-14 | Conversion | 1,791,860 | -- | -- | 43% 4.19M to 5.98M | |
| 15-Apr-14 8:46 PM View: | Cerulean Pharma Inc. (DARE) | 15-Apr-14 | Market Purchase Duplicate | 1,470,580 | $7.00 | $10,294,100.00 | 25% 5.98M to 7.45M | (98%) |
| 11-Feb-14 9:57 PM View: | Genocea Biosciences, Inc. (GNCA) | 10-Feb-14 | Conversion Duplicate | 1,895,860 | -- | -- | 100% 0 to 1.9M | |
| 11-Feb-14 9:57 PM View: | Genocea Biosciences, Inc. (GNCA) | 10-Feb-14 | Purchase Duplicate | 232,820 | $12.00 | $2,793,840.00 | 12% 1.9M to 2.13M | |
| 07-Feb-14 12:06 PM View: | Trevena, Inc. (TRVN) | 05-Feb-14 | Conversion | 3,339,280 | -- | -- | 100% 3.34M to 6.68M | |
| 07-Feb-14 12:06 PM View: | Trevena, Inc. (TRVN) | 05-Feb-14 | Purchase | 472,405 | $7.00 | $3,306,840.00 | 7% 6.68M to 7.15M | |
| 07-Oct-13 2:17 PM View: | Fate Therapeutics Inc (FATE) | 04-Oct-13 | Conversion Duplicate | 1,511,410 | -- | -- | 21% 7.37M to 8.88M | |
| 07-Oct-13 2:17 PM View: | Fate Therapeutics Inc (FATE) | 04-Oct-13 | Acquisition (other) Duplicate | 128,446 | $6.00 | $770,676.00 | 1% 8.88M to 9.01M | |
| 07-Oct-13 2:17 PM View: | Fate Therapeutics Inc (FATE) | 04-Oct-13 | Purchase Duplicate | 833,333 | $6.00 | $5,000,000.00 | 9% 9.01M to 9.84M | |
| 27-Sep-13 5:21 PM View: | Dnib Unwind, Inc. (BIND) | 25-Sep-13 | Conversion | 1,992,250 | -- | -- | 100% 1.99M to 3.98M | |
| 27-Sep-13 5:21 PM View: | Dnib Unwind, Inc. (BIND) | 25-Sep-13 | Purchase | 26,000 | $15.00 | $390,000.00 | < 1% 3.98M to 4.01M |